N/A
N=68
China Antiretroviral Treatment Adherence for Life
HIV Infections
Bottom Line
View on ClinicalTrials.gov: NCT00661258 ↗Enrolled (actual)
68
Serious AEs
0.0%
Results posted
May 2017
Primary outcome: Primary: Mean Adherence, as Measured by Electronic Drug Monitors (EDM) — 96.5; 84.5; 96.4; 84.1 percentage of doses taken on time
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Electronic drug monitoring feedback data (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Boston University
- Primary completion
- Nov 2007
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Adherence, as Measured by Electronic Drug Monitors (EDM) |
96.5; 84.5; 96.4; 84.1 | — |
| SECONDARY Change in CD4 Count |
90.0; -8.8 | — |
Summary
This study focuses on collecting and analyzing quantitative data related to adherence to antiretroviral treatment from patients in Dali, China, over a one-year time-frame and generating preliminary data on an intervention designed to improve adherence to antiretroviral treatment among the study population.
Eligibility Criteria
Inclusion Criteria
- Patients who are 18 years of age or older, currently on antiretroviral treatment or about to begin it, live in the study catchment area, and are willing to provide informed consent.
Exclusion Criteria
- Persons below the age of 18 years, persons who are not currently on or about to start antiretroviral treatment, persons who live outside the study catchment area, or person not willing to provide informed consent.
Data sourced from ClinicalTrials.gov (NCT00661258). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.